Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer
FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON)
Read More 5 minute read Energy Industry News What the Blackstone–Enverus deal tells us about the future of oil and gas strategy Blackstone’s $6.5B Enverus buyout reveals how oil and gas strategy is shifting from drilling assets to digital analytics and emissions intelligence. byPallavi MadhirajuSeptember 16, 2025